Pathology News

In this interview, David Braun, MD, PhD, and Patrick Kenney, MD, describe their practices and touch on unmet needs in kidney cancer treatment.

More than half of human cancers, called “non-inflamed” or “cold” tumors, are not being effectively infiltrated by the cancer-fighting T cells. Essentially, the soldiers are excluded from the battlefield. Yale Cancer Center researchers want to know why.

One of the largest multiomics analyses to date examines hallmarks associated with COVID-19 severity and mortality, and how these factors interact with one another.

Inhibiting a certain protein in mice reduced obesity-induced liver tumor development, Yale researchers found. It could reveal a future treatment route.

Demetrios Braddock, MD, PhD, Associate Professor of Pathology, is among 10 physician-scientists named as recipients of the Harrington Discovery Institute 2024 Scholar-Innovator Award.

Yale Cancer Center researchers at Yale School of Medicine analyzed the genetic landscape of 66 tumors, the largest series of cervical neuroendocrine tumors ever reported in scientific literature.

Yale Pathology Labs joins medical laboratories across the country in celebrating National Medical Laboratory Professionals Week, April 14 to 20.

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Yale Pathology Labs, with its mobile Laboratory-in-a-Van, has surpassed its goal of offering at least 400 free saliva-based PCR COVID tests to the community.